Monitoring of monoclonal antibodies for COVID-19: weekly report published

EMA starts review of conditional marketing authorisation application for Skycovion COVID-19 vaccine

Monitoring of antivirals for COVID-19: new report published

Monitoring of monoclonal antibodies for COVID-19: weekly report published

Aggiornamento Registro Anticorpi monoclonali COVID-19

AIFA authorises the therapeutic use of the monoclonal Evusheld for the early treatment of COVID-19 in subjects at risk of progression

EMA reviewing data on sabizabulin for COVID-19

Modifica Registro ANTIVIRALI ORALI COVID-19

Twelfth AIFA Report on the surveillance of anti-COVID-19 vaccines

Monitoring of monoclonal antibodies for COVID-19: weekly report published

Monitoring of antivirals for COVID-19: new report published

ECDC and EMA update recommendations on additional booster doses of mRNA COVID-19 vaccines

COVID-19: extension of the target recipients of the second booster dose

Updated joint statement from ECDC and EMA on additional booster doses of COVID-19 vaccines

Monitoring of antivirals for COVID-19: new report published

Monitoring of monoclonal antibodies for COVID-19: weekly report published

EMA recommends Valneva’s COVID-19 vaccine for authorisation in the EU

EMA recommends authorisation of Nuvaxovid for adolescents aged 12 to 17

Monitoring of antivirals for COVID-19: new report published

Monitoring of monoclonal antibodies for COVID-19: weekly report published